Pharmacological Targets for Correction of Dyslipidemias. Opportunities and Prospects of Therapeutic Use


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The review summarizes literature data on existing pharmacological agents and novel drug preparations developed for correction of dyslipidemias and molecular mechanisms of their action. Much attention is paid to analysis of experimental and clinical studies aimed at identification of new pharmacological targets for correction of dyslipidemias and characterization of approaches increasing high density lipoproteins functionality. The implementation of alternative pharmacological agents with new alternative mechanisms of action may improve the effectiveness of traditional treatment in the future.

About the authors

V. A. Kudinov

Institute of Biomedical Chemistry (IBMC)

Email: tz-post@list.ru
Russian Federation, ul. Pogodinskaya 10, Moscow, 119121

T. S. Zakharova

Institute of Biomedical Chemistry (IBMC)

Author for correspondence.
Email: tz-post@list.ru
Russian Federation, ul. Pogodinskaya 10, Moscow, 119121

T. I. Torkhovskaya

Institute of Biomedical Chemistry (IBMC)

Email: tz-post@list.ru
Russian Federation, ul. Pogodinskaya 10, Moscow, 119121

O. M. Ipatova

Institute of Biomedical Chemistry (IBMC)

Email: tz-post@list.ru
Russian Federation, ul. Pogodinskaya 10, Moscow, 119121

A. I. Archakov

Institute of Biomedical Chemistry (IBMC)

Email: tz-post@list.ru
Russian Federation, ul. Pogodinskaya 10, Moscow, 119121

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Pleiades Publishing, Ltd.